抗血小板药(Antiplatelet drugs)或血小板功能抑制剂(Platelet function inhibitor)是一组通过各种不同机制以抑制血小板活化反应并能阻止血小板参与血栓形成的药物,临床上主要用于防治动脉和静脉血栓性疾病。近年来有关此类药物的研究有了很大的发展,本文就抗血小板药物的某些进展作一简要综述。某些进展环氧酶抑制剂在血小板受刺激时,可激活磷酯酶,该酶引起花生四烯酸(AA)的释放。血小板中的 Antiplatelet drugs or platelet function inhibitors are drugs that inhibit platelet activation through a variety of mechanisms and prevent platelets from participating in thrombosis. They are mainly used to prevent arterial and venous thrombosis Sexually transmitted diseases. In recent years, great progress has been made in the research of such drugs. This article gives a brief review of some progress of antiplatelet drugs. Some Progress Epoxyzyme inhibitors can activate phospholipases, which cause the release of arachidonic acid (AA), when stimulated by platelets. In platelets